about
Nkarta Inc is a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf engineered natural killer (NK) cell therapies. The company is engaged in leveraging the natural potent power of NK cells to identify and ...
Read More
2.88
0.05
(1.77%)
385.8K
XNAS Volume
XNAS 21 Sep, 2026 5:30 PM (EDT)
Board Meeting
The next board meeting for Nkarta Inc is on 23 Sep 2026 for the purpose of Stifel 2026 Virtual Immunology and Inflammation Forum
See details
Not Eligible
Expensive Valuation
Technically Neutral
Nkarta Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..